Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emerging antibody-drug conjugates for treating lymphoid malignancies.
Wolska-Washer A, Robak P, Smolewski P, Robak T. Wolska-Washer A, et al. Among authors: robak t, robak p. Expert Opin Emerg Drugs. 2017 Sep;22(3):259-273. doi: 10.1080/14728214.2017.1366447. Epub 2017 Aug 28. Expert Opin Emerg Drugs. 2017. PMID: 28792782 Review.
Rituximab for chronic lymphocytic leukemia.
Robak T. Robak T. Expert Opin Biol Ther. 2012 Apr;12(4):503-15. doi: 10.1517/14712598.2012.665444. Epub 2012 Feb 28. Expert Opin Biol Ther. 2012. PMID: 22369284 Review.
Anti-CD37 antibodies for chronic lymphocytic leukemia.
Robak T, Robak P. Robak T, et al. Among authors: robak p. Expert Opin Biol Ther. 2014 May;14(5):651-61. doi: 10.1517/14712598.2014.890182. Epub 2014 Feb 20. Expert Opin Biol Ther. 2014. PMID: 24555705 Review.
Emerging immunological drugs for chronic lymphocytic leukemia.
Robak P, Smolewski P, Robak T. Robak P, et al. Among authors: robak t. Expert Opin Emerg Drugs. 2015 Sep;20(3):423-47. doi: 10.1517/14728214.2015.1046432. Epub 2015 Jul 11. Expert Opin Emerg Drugs. 2015. PMID: 26153226 Review.
775 results